Antibiotics directly to the lungs for hospital pneumonia
Treatments studied
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial tests a way to give antibiotics directly to the lungs (inhaled or nebulized) for people hospitalized with moderate to severe pneumonia. The goal is to see if this local treatment works better than standard antibiotics alone and helps you recover faster.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older and have been admitted to the hospital within the last 24 hours.
- You have a new chest X-ray or CT finding that looks like pneumonia, along with symptoms like fever, cough, or chest pain.
- You have a moderate to severe pneumonia risk score (CURB-65 of 3 to 5).
- You have a high inflammation marker (CRP over 50) or a fever above 38°C (100.4°F).
- You have not tested positive for COVID-19 or the flu.
- You can give informed consent and do not have conditions like severe kidney problems, certain heart rhythm issues, or allergies to the study antibiotics.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new medication called OPT101 for people hospitalized with pneumonia and sepsis (a severe infection that affects the whole body). The drug may help reduce inflammation and improve oxygen levels. The study focuses on those who need extra oxygen but are not yet on a breathing machine.
This trial tests whether adding an experimental herbal medicine (NRICM102) to standard antibiotics can help adults hospitalized with community-acquired pneumonia recover faster. It is a phase 2 study, meaning the treatment is still being tested for safety and effectiveness.
This study tests an inhaled antibiotic (lexofloxacin) compared to standard care for adults hospitalized with pneumonia. It aims to see if the inhaled treatment works as well or better and is safe.
This trial compares how long antibiotics should be given to people hospitalized with moderately severe community-acquired pneumonia. It uses your early improvement to see which antibiotic duration works best and safely.
This trial is testing a new way to choose antibiotics for people with COPD who get pneumonia and need intensive care. The goal is to find the best treatment using a personalized approach.
This trial tests different treatments for serious lung infections in people who are already in the hospital. It may help doctors learn which treatment works best for recovery and survival when pneumonia-like illness is suspected.
Hear when a new Community Acquired Pneumonia (CAP) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.